Reviewed by Ashley Harwyn, PA-C | A4M Board Certified | Updated September 3, 2026
Most pages about this procedure tell you it is safe, natural and effective. Two of those three are defensible. This page will show you the actual evidence, including the part that argues against it, because you are being asked to pay for something out of pocket and you deserve to make that decision with the real numbers in front of you.
Hear from Ashley
What the randomized trial actually found
Fifty-two women were randomized, half to a single PRP injection into the anterior vaginal wall and half to saline, then followed for six months. Neither the participants nor the assessors knew which they had received [1].
The headline result is the one in the chart above. On the Patient Global Impression of Improvement, 69.2 percent of the PRP group reported improvement at six months against 34.6 percent of the placebo group, and that difference was statistically significant [1].
The part that is usually left out
When the researchers looked at the components of sexual function separately, desire, arousal, lubrication and orgasm, every one of them moved in the right direction and not one of them reached statistical significance against placebo on its own [1].
Were women like you actually studied?
The trial enrolled sexually active premenopausal women between 18 and 50, without severe sexual dysfunction [1]. That is a narrower group than the women this treatment is usually marketed to.
If you are postmenopausal, or your symptoms are severe, the honest position is that the evidence for you is weaker rather than stronger. It may still be a reasonable thing to try. It is not a thing anyone can promise you, and the hormonal picture usually deserves attention first through hormone therapy or local estrogen.
Is the O-Shot the Right Starting Point?
Select what you have been experiencing. This is an educational reflection tool that points toward what is worth evaluating, not a diagnosis. Nothing is stored or sent anywhere.
Tap all that apply
What the evidence says for you
Based on what you selected, these are the areas a clinician would want to look at together. This is a starting point for a conversation, not a diagnosis.
The only way to know what is driving your own symptoms is to have them evaluated by a clinician with the time to look properly.
Book an evaluation →Educational only. Not a diagnosis or a substitute for clinical evaluation.
Will the O-Shot help urinary incontinence?
This is where this page will differ from most others in Charleston, and it is the section worth reading twice if leaking is what brought you here.
A systematic review examined PRP for both female sexual dysfunction and stress urinary incontinence across 12 studies and 327 women. In the one randomized comparison it identified, the midurethral sling performed significantly better than PRP injections for stress incontinence, on both of the measures used [2].
How strong is the evidence, honestly?
The same systematic review pooled 12 studies covering 327 women, with a mean age of 51. Improvements were consistent across the scales used: the Female Sexual Function Index rose from 14 to 28, and the Vaginal Health Index from 11 to 19 [2].
Then it states its own conclusion plainly, and it is worth quoting rather than paraphrasing: the level of current evidence is low, because of methodological problems in the available studies [2]. Small samples, inconsistent preparation methods, short follow-up. Eleven of the twelve studies were observational rather than randomized.
That is the true state of it. Promising early results, one good randomized trial, and not yet the body of evidence that would let anyone responsibly promise you an outcome.
Improved overall sexual function in one randomized trial: 69.2 percent reported improvement against 34.6 percent on placebo at six months. A strong safety record, with under one percent adverse events across 327 women, all minor and all resolved.
A promised improvement in any single thing. Desire, arousal, lubrication and orgasm each moved the right way but none reached significance alone. And for stress urinary incontinence the midurethral sling outperformed PRP in the one randomized comparison available.
What is the safety record?
This is the strongest part of the picture and it is genuinely reassuring. Across 327 women in the systematic review, fewer than one percent experienced any adverse event: three patients in total, two who reported extreme arousal and one with temporary urinary retention. All three resolved without further treatment [2]. The randomized trial reported no serious adverse events [1].
Because the preparation uses your own platelets, drawn from your own blood on the day, there is no donor material and no risk of an allergic reaction to a foreign substance.
Why the subscale result is the part to hold on to
It is tempting to read one strong headline number and stop there, and most pages about this procedure do exactly that. The more useful reading is that the overall impression of improvement moved clearly while the individual components did not reach significance on their own. That pattern is common in small trials and it has a specific meaning: the finding is real enough to take seriously and too coarse to promise you a particular outcome.
So if someone tells you this will fix desire specifically, or lubrication specifically, they are describing something the trial did not show. The honest version is that women in the treated group were more likely to say they were better overall, which is a genuine result and a smaller claim than the one usually made.
How the assessment works in Mount Pleasant and Charleston
A conversation comes before any procedure is booked. What you are actually experiencing and for how long, where you are in the menopause transition, what medications you take, whether pain or incontinence is part of the picture, and what has already been tried.
A good deal of what brings women to this page is better addressed by treating vaginal atrophy, reviewing hormones, or referring for pelvic floor therapy. Where that is true you will be told, and the relevant laboratory work comes before any decision.
Solcara Health sees patients at two locations. The Mount Pleasant office is at 496 Bramson Ct, Ste 120, convenient to Old Village, I'On, Park West and Daniel Island. The downtown practice is at The Longevity Club, 163 Rutledge Ave, Ste 202, in the medical district near MUSC and easy to reach from Harleston Village, West Ashley, Sullivan's Island and Isle of Palms.
Ashley Harwyn, PA-C is board certified through the American Academy of Anti-Aging Medicine. This procedure is assessed here against the published evidence rather than against a brochure, which sometimes means the answer is that something else should come first.
If dryness or discomfort is the main problem
Local estrogen is better established for vaginal atrophy and is often the right first step. Read whether vaginal estrogen is safe after the 2026 FDA label change.
If leaking is the main problem
Stress incontinence deserves its own assessment before any procedure is chosen. See treatment for urinary stress incontinence and understanding urinary incontinence and vaginal laxity.
If the wider hormonal picture is unclear
Symptoms that arrive together usually share a cause worth measuring. See bioidentical hormone therapy and full panel lab testing.
What it costs, and what it does not cover
This is not covered by insurance and cannot be billed to it, because it is not an FDA-approved indication. Any clinic telling you otherwise is mistaken. Pricing is discussed openly before you commit to anything.
Questions women actually ask
Ashley Harwyn, PA-C
A4M Board Certified · Founder, Solcara Health
Online
Tap a question to ask
Ashley Harwyn, PA-C
Founder, Solcara Health · Board Certified in Anti-Aging and Functional Medicine (A4M)
Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats women as whole people and tells them the truth about what the evidence does and does not support.
Full bio →References
U.S. Food and Drug Administration, HHS, and The Menopause Society sources.
- Clarke B, Gaddam N, Garcia B, Iglesia CB, Podolsky R, Dieter AA. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstetrics and Gynecology. 2026;147(5):627-635. Read the study on PubMed
- Dankova I, Pyrgidis N, Tishukov M, et al. Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review. Biomedicines. 2023;11(11):2919. Read the study on PubMed
Be taken seriously, and told the truth
Book an evaluation at The Longevity Club, 163 Rutledge Avenue downtown, or our Mount Pleasant office.
BOOK A CONSULTATION →Or call 843-981-0870
Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. It describes a regulatory labeling change and general treatment categories; it is not a recommendation that any individual start, stop, or change a medication. Hormone therapy of any kind, including local vaginal estrogen, requires evaluation by a qualified, licensed clinician who knows your personal and family history. Consult a qualified healthcare provider before making medical decisions. Information reflects sources available as of August 20, 2026.
Ashley Harwyn, PA-C, is Board Certified in Anti-Aging and Functional Medicine (A4M) and the founder of Solcara Health. Solcara serves South Carolina from Downtown Charleston (163 Rutledge Ave, Ste 202, The Longevity Club) and Mt. Pleasant (496 Bramson Ct, Ste 120).




O-Shot® FAQ's
Is Fotona IntimaLase® safe?
Absolutely! It's a safe and FDA-approved procedure with minimal risks. We also use the most advanced laser technology called the G-Runner which eliminates the need for manual positioning of the handpiece. This improves accuracy and precision of Er:YAG laser delivery, providing truly homogenous coverage of the vaginal mucosa tissue.
The benefits of G-Runner™ include:
• Supreme accuracy and precision of laser energy deposition in vaginal mucosa
• Easy to use, fully automatic operation
• Short treatment time
• Increased comfort for the patient and operator

Quick Links


